Literature DB >> 25721508

Multidrug resistant tuberculosis.

James Millard1, Cesar Ugarte-Gil2, David A J Moore3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25721508     DOI： 10.1136/bmj.h882

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  20 in total

Review 1.  Strategic Moves of "Superbugs" Against Available Chemical Scaffolds: Signaling, Regulation, and Challenges.

Authors:  Bikash Baral; M R Mozafari
Journal:  ACS Pharmacol Transl Sci       Date:  2020-04-13

2.  Causal inference with multiple concurrent medications: A comparison of methods and an application in multidrug-resistant tuberculosis.

Authors:  Arman Alam Siddique; Mireille E Schnitzer; Asma Bahamyirou; Guanbo Wang; Timothy H Holtz; Giovanni B Migliori; Giovanni Sotgiu; Neel R Gandhi; Mario H Vargas; Dick Menzies; Andrea Benedetti
Journal:  Stat Methods Med Res       Date:  2018-10-31       Impact factor: 3.021

3.  Bibliometric analysis of worldwide publications on multi-, extensively, and totally drug - resistant tuberculosis (2006-2015).

Authors:  Waleed M Sweileh; Adham S AbuTaha; Ansam F Sawalha; Suleiman Al-Khalil; Samah W Al-Jabi; Sa'ed H Zyoud
Journal:  Multidiscip Respir Med       Date:  2017-01-11

4.  M2 macrophages or IL-33 treatment attenuate ongoing Mycobacterium tuberculosis infection.

Authors:  A R Piñeros; L W Campos; D M Fonseca; T B Bertolini; A F Gembre; R Q Prado; J C Alves-Filho; S G Ramos; M Russo; V L D Bonato
Journal:  Sci Rep       Date:  2017-01-27       Impact factor: 4.379

5.  Novel Aryl Substituted Pyrazoles as Small Molecule Inhibitors of Cytochrome P450 CYP121A1: Synthesis and Antimycobacterial Evaluation.

Authors:  Ismail M Taban; Hosam E A E Elshihawy; Beyza Torun; Benedetta Zucchini; Clare J Williamson; Dania Altuwairigi; Adeline S T Ngu; Kirsty J McLean; Colin W Levy; Sakshi Sood; Leonardo B Marino; Andrew W Munro; Luiz Pedro S de Carvalho; Claire Simons
Journal:  J Med Chem       Date:  2017-12-07       Impact factor: 7.446

Review 6.  New Insights in to the Intrinsic and Acquired Drug Resistance Mechanisms in Mycobacteria.

Authors:  Mohammad J Nasiri; Mehri Haeili; Mona Ghazi; Hossein Goudarzi; Ali Pormohammad; Abbas A Imani Fooladi; Mohammad M Feizabadi
Journal:  Front Microbiol       Date:  2017-04-25       Impact factor: 5.640

7.  Prevalence and risk factors of multi-drug resistant tuberculosis in Dalian, China.

Authors:  Xin-Tong Lv; Xi-Wei Lu; Xiao-Yan Shi; Ling Zhou
Journal:  J Int Med Res       Date:  2017-03-27       Impact factor: 1.671

8.  Novel targeting of PEGylated liposomes for codelivery of TGF-β1 siRNA and four antitubercular drugs to human macrophages for the treatment of mycobacterial infection: a quantitative proteomic study.

Authors:  Ning-Kui Niu; Juan-Juan Yin; Yin-Xue Yang; Zi-Li Wang; Zhi-Wei Zhou; Zhi-Xu He; Xiao-Wu Chen; Xueji Zhang; Wei Duan; Tianxin Yang; Shu-Feng Zhou
Journal:  Drug Des Devel Ther       Date:  2015-08-07       Impact factor: 4.162

Review 9.  Drug-resistant TB: deadly, costly and in need of a vaccine.

Authors:  Janna Manjelievskaia; Dara Erck; Samina Piracha; Lewis Schrager
Journal:  Trans R Soc Trop Med Hyg       Date:  2016-03       Impact factor: 2.184

10.  Sequelae of multidrug-resistant tuberculosis: protocol for a systematic review and meta-analysis.

Authors:  Kefyalew Addis Alene; Archie C A Clements; Emma S McBryde; Ernesto Jaramillo; Knut Lonnroth; Debebe Shaweno; Kerri Viney
Journal:  BMJ Open       Date:  2018-02-10       Impact factor: 2.692
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.